Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening

Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening

The present investigation aims to examine the role of α-synuclein seed amplification assays for screening Parkinson’s disease. Parkinson’s disease (PD) is a debilitating neurodegenerative disorder caused by the loss of dopaminergic neurons in the midbrain, leading to symptoms such as tremors, bradyk...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alan D. Kaye, Kassady A. Perkinson, Noah J. Spillers, Alexis J. Vega, Caylin J. Roberts, Evan M. Downs, Melissa M. Sheth, David W. McGregor, Shahab Ahmadzadeh, Jibin Mathew, Sahar Shekoohi
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Current Issues in Molecular Biology
Subjects:	α-synuclein Parkinson’s disease screening seeding amplification assay
Online Access:	https://www.mdpi.com/1467-3045/46/11/757
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Pathological α-synuclein elicits granulovacuolar degeneration independent of tau
by: Dylan J. Dues, et al.
Published: (2025-06-01)

Alpha-Synuclein Dysregulation in Systemic Pathophysiology of Synucleinopathies
by: Hallie H. Dolin, et al.
Published: (2025-07-01)

Effect of hydrogen sulfide on alpha-synuclein aggregation and cell viability
by: Elena A. Ostrakhovitch, et al.
Published: (2025-05-01)

THE LEVEL OF Α-SYNUCLEIN IN THE PLASMA AS A BIOMARKER OF PAIN IN PARKINSON'S DISEASE TAKING INTO ACCOUNT THE MOTOR SUBTYPES
by: K.A. Tarianyk
Published: (2024-07-01)

Engineered sequestrins inhibit aggregation of pathogenic alpha-synuclein mutants
by: Linnea Charlotta Hjelm, et al.
Published: (2025-05-01)

Experimental and computational insights into the therapeutic mechanisms of resveratrol in a Drosophila α-synuclein model of Parkinson’s disease
by: Amos Olalekan Abolaji, et al.
Published: (2025-05-01)

Photochemically synthesized gold nanoparticles conjugated with Boswellic acid inhibit alpha synuclein aggregation and delay fibrillation kinetics
by: Masoumeh Gharb, et al.
Published: (2025-07-01)

Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease
by: Wenlong Zhang, et al.
Published: (2024-11-01)

Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to α-synuclein toxic species
by: Mª Salomé Sirerol-Piquer, et al.
Published: (2025-03-01)

Trans-sodium crocetinate ameliorates Parkinson-like disease caused by bisphenol A through inhibition of apoptosis and reduction of α-synuclein in rats
by: Majid Keshavarzi, et al.
Published: (2025-02-01)

Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
by: Martin Schuler, et al.
Published: (2025-04-01)

Multivalent design of the monoclonal SynO2 antibody improves binding strength to soluble α-Synuclein aggregates
by: Inga Petersen, et al.
Published: (2023-12-01)

Discovery of <i>N</i>-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
by: Haiyang Zhao, et al.
Published: (2025-07-01)

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
by: Jingfeng Liang, et al.
Published: (2025-08-01)

GDNF attenuates a-synuclein aggregation-induced damage to VTA-NAc dopaminergic transmission and alleviates depression-like behaviors in mice
by: Jing Chen, et al.
Published: (2025-08-01)

RETRACTED ARTICLE: Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5 – implications for dementia with Lewy bodies
by: Cassia R Overk, et al.
Published: (2014-05-01)

Autoantibody profiles in Alzheimer´s, Parkinson´s, and dementia with Lewy bodies: altered IgG affinity and IgG/IgM/IgA responses to alpha-synuclein, amyloid-beta, and tau in disease-specific pathological patterns
by: Luisa Knecht, et al.
Published: (2024-12-01)

Neuroblastoma: morphological pattern, molecular genetic features, and prognostic factors
by: A. M. Stroganova, et al.
Published: (2016-04-01)

Unraveling the mystery: How autophagy deficiency in dopaminergic neurons drives human Parkinson’s disease
by: Sachiko Noda, et al.
Published: (2025-07-01)

Current strategies in the management of dementia with lewy bodies and future directions based on disease pathophysiology
by: Daniel Erskine, et al.
Published: (2025-07-01)

TUDCA combined with Syndopa protects the midbrain and gut from MPTP toxicity in a Parkinson’s disease mouse model: Immunohistochemical evidence
by: Mahalakshmi Rajan, et al.
Published: (2025-08-01)

Astrocyte alterations in α-synucleinopathies
by: Manuela Rodríguez-Castañeda, et al.
Published: (2025-08-01)

Glutamate-associated research in Parkinson’s disease: a bibliometric analysis
by: Yan-Jun Chen, et al.
Published: (2025-08-01)

RESEARCH AND DEVELOPMENT CONTROL METHOD PATHOGENIC PRION INFECTIONS SECONDARY RAW MEAT INDUSTRY
by: A. Y. Prosekov, et al.
Published: (2016-10-01)

Integrated double signal amplification systems with ELISA assay for sensitive detection of tylosin in food
by: Shan Shan, et al.
Published: (2024-12-01)

Recent Advances in the Development of Functional Nucleic Acid Biosensors Based on Aptamer-Rolling Circle Amplification
by: Ce Liu, et al.
Published: (2025-05-01)

Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson’s disease
by: Hayam Ali AlRasheed, et al.
Published: (2025-05-01)

Effects of Sediment Thickness upon Seismic Amplification in the Urban Area of Chiapa de Corzo, Chiapas, Mexico
by: Roberto Moreno Ceballo, et al.
Published: (2019-04-01)

Sputtering yield amplification of Si through the addition of Cu, Mo, or Ta
by: J Cruz, et al.
Published: (2025-01-01)

DEVELOPMENT OF MURINE STEM CELLS WITH CONDITIONAL KNOCKOUT OF HUMANIZED SNCA GENE
by: E. A. Patrakhanov, et al.
Published: (2023-02-01)

Protein regulatory network mediated by palmitoylation modifications in the pathological progression of Parkinson’s disease: a narrative review
by: Jingjing Liu, et al.
Published: (2025-07-01)

Investigation of the substrate properties of fluorescently labeled pyrimidine triphosphates in recombinase polymerase amplification
by: A. S. Epifanov, et al.
Published: (2024-11-01)

Polymorphism of monogenic scab resistance loci in apple varieties
by: A. S. Lyzhin, et al.
Published: (2020-04-01)

Prevalence of Plasmodium falciparum plasmepsin2/3 gene duplication in Africa and Asia: a systematic review and meta-analysis
by: Karol J. Marwa, et al.
Published: (2025-08-01)

Skin biopsy: an emerging tool for the diagnosis of protein misfolding diseases of the central nervous system
by: Wei Zhu, et al.
Published: (2025-07-01)

DNA Damage Response Regulation Alleviates Neuroinflammation in a Mouse Model of α-Synucleinopathy
by: Sazzad Khan, et al.
Published: (2025-06-01)

Protective effects of paederoside in rotenone-induced cellular models of Parkinson’s disease
by: Juan Lang, et al.
Published: (2025-08-01)

Research on Bacteria Diversity of Marine Ranch in Zhuhai Wailingding Based on eDNA Technology
by: Nengwei ZANG, et al.
Published: (2023-02-01)

Study of the Effect of Compensation Device with 6% Reactance Rate on 4 th Harmonic Amplification
by: PAN Caimin
Published: (2015-01-01)